paeonol has been researched along with dinoprostone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, HS; Choi, JG; Jang, HJ; Jeong, SI; Kang, OH; Kim, JH; Kim, MS; Kwon, DY; Lee, YS; Oh, YC | 1 |
| Ao, G; Cao, Q; Chen, D; Cui, J; Wu, D | 1 |
| Himaya, SW; Kim, SK; Qian, ZJ; Ryu, B | 1 |
| Li, M; Tan, SY; Wang, XF | 1 |
| Fan, Z; Liu, Z; Peng, Y; Wang, G; Zheng, X; Zhou, H; Zhu, X | 1 |
5 other study(ies) available for paeonol and dinoprostone
| Article | Year |
|---|---|
Inhibition of LPS-induced iNOS, COX-2 and inflammatory mediator expression by paeonol through the MAPKs inactivation in RAW 264.7 cells.
Topics: Acetophenones; Analgesics; Animals; Anti-Inflammatory Agents; Cell Survival; Cyclooxygenase 2; Cynanchum; Dinoprostone; Edema; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type II; Pain; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Sprague-Dawley | 2009 |
In vitro and in vivo evaluation of ibuprofen-paeonol conjugate.
Topics: Acetic Acid; Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cytoprotection; Dinoprostone; Disease Models, Animal; Drug Combinations; Drug Compounding; Drug Stability; Edema; Esterification; Gastric Mucosa; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Injections, Intravenous; Intestinal Absorption; Magnetic Resonance Spectroscopy; Malondialdehyde; Mice; Nitric Oxide; Pain; Particle Size; Protective Agents; Rats; Stomach; Technology, Pharmaceutical; Xylenes | 2011 |
Paeonol from Hippocampus kuda Bleeler suppressed the neuro-inflammatory responses in vitro via NF-κB and MAPK signaling pathways.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Dinoprostone; Humans; Inflammation; Lipopolysaccharides; Mice; Microglia; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Signal Transduction; Smegmamorpha | 2012 |
Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE₂ synthesis and COX-2 expression.
Topics: Acetophenones; Animals; Apoptosis; Caspase 3; Celecoxib; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation, Neoplastic; Humans; Membrane Potential, Mitochondrial; Mice; NF-kappa B; Pyrazoles; Sulfonamides | 2014 |
Paeonol alleviates primary dysmenorrhea in mice via activating CB2R in the uterus.
Topics: Acetophenones; Animals; Calcium; Dinoprostone; Dysmenorrhea; Estradiol; Female; Mice, Inbred ICR; Molecular Docking Simulation; Myocytes, Smooth Muscle; Myometrium; Oxytocin; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha; Uterine Contraction; Uterus | 2020 |